ArticleRespiratory research2023

Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses.

Ayobami Akenroye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.